Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-13

Clinical Trial Update: Increasing Patching for Amblyopia in Children 3 to < 8 Years Old [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating higher patching regimens for amblyopia in children aged 3 to under 8 has completed; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Amblyopia | Phase 3 | Status: COMPLETED | Results posted: 2013-11-13